Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto M Martelli

Showing results (1-10 of 213) with videos related to

Pageof 22
Sort By:
Pharmacology & Therapeutics|January 20, 2004
Nuclear inositides: facts and perspectivesAlberto M Martelli, Lucia Manzoli, Lucio Cocco
Cell Cycle (Georgetown, Tex.)|February 15, 2014
GSK-3β: a key regulator of breast cancer drug resistanceAlberto M Martelli, Francesca Buontempo, Camilla Evangelisti
Clinical Science (London, England : 1979)|March 11, 2018
Drug discovery targeting the mTOR pathwayAlberto M Martelli, Francesca Buontempo, James A McCubrey
International Journal of Molecular Sciences|February 13, 2020
The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic LeukemiaFrancesca Chiarini, Francesca Paganelli, Alberto M Martelli, et al.
Advances in Enzyme Regulation|July 19, 2005
Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemiaLucio Cocco, Lucia Manzoli, Giandomenico Palka, et al.
Molecular Cancer Therapeutics|July 5, 2006
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathwaysMaria Nyåkern, Alessandra Cappellini, Irina Mantovani, et al.
Advances in Enzyme Regulation|December 8, 2004
Significance of subnuclear localization of key players of inositol lipid cycleLucio Cocco, Lucia Manzoli, Ottavio Barnabei, et al.
International Journal of Molecular Sciences|June 29, 2018
Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An UpdateCamilla Evangelisti, Francesca Chiarini, James A McCubrey, et al.
Oncotarget|July 31, 2010
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patientsAlberto M Martelli, Camilla Evangelisti, Francesca Chiarini, et al.
Trends in Pharmacological Sciences|December 16, 2014
Current treatment strategies for inhibiting mTOR in cancerFrancesca Chiarini, Camilla Evangelisti, James A McCubrey, et al.
Pageof 22

Showing results (1-10 of 213) with videos related to

Sort By:
Pageof 22
Pharmacology & Therapeutics|January 20, 2004
Nuclear inositides: facts and perspectivesAlberto M Martelli, Lucia Manzoli, Lucio Cocco
Cell Cycle (Georgetown, Tex.)|February 15, 2014
GSK-3β: a key regulator of breast cancer drug resistanceAlberto M Martelli, Francesca Buontempo, Camilla Evangelisti
Clinical Science (London, England : 1979)|March 11, 2018
Drug discovery targeting the mTOR pathwayAlberto M Martelli, Francesca Buontempo, James A McCubrey
International Journal of Molecular Sciences|February 13, 2020
The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic LeukemiaFrancesca Chiarini, Francesca Paganelli, Alberto M Martelli, et al.
Advances in Enzyme Regulation|July 19, 2005
Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemiaLucio Cocco, Lucia Manzoli, Giandomenico Palka, et al.
Molecular Cancer Therapeutics|July 5, 2006
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathwaysMaria Nyåkern, Alessandra Cappellini, Irina Mantovani, et al.
Advances in Enzyme Regulation|December 8, 2004
Significance of subnuclear localization of key players of inositol lipid cycleLucio Cocco, Lucia Manzoli, Ottavio Barnabei, et al.
International Journal of Molecular Sciences|June 29, 2018
Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An UpdateCamilla Evangelisti, Francesca Chiarini, James A McCubrey, et al.
Oncotarget|July 31, 2010
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patientsAlberto M Martelli, Camilla Evangelisti, Francesca Chiarini, et al.
Trends in Pharmacological Sciences|December 16, 2014
Current treatment strategies for inhibiting mTOR in cancerFrancesca Chiarini, Camilla Evangelisti, James A McCubrey, et al.
Pageof 22